-
Mashup Score: 4Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study - 1 year(s) ago
Objective Antiphospholipid syndrome (APS) is defined by the association of thromboembolic and/or obstetrical clinical manifestations and the presence of antiphospholipid antibodies. The objective of our study was to evaluate the impact of the triple-positive profile in a cohort of 204 APS patients. Methods We conducted a retrospective study, including patients with primary or secondary APS,…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 3
Despite treatment adhering to international recommendations, a proportion of women with antiphospholipid syndrome developed a thrombotic or severe haemorrhagic complication related to pregnancy, most frequently in the post-partum period. Lupus anticoagulant and placental insufficiency were risk factors for these life-threatening complications. These complications are difficult to prevent, but…
Source: The Lancet RheumatologyCategories: Latest Headlines, RheumatologyTweet-
NEW RESEARCH in our Dec issue—Anne Murarasu and colleagues @APHP characterise a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with #antiphospholipid syndrome in France https://t.co/bhvOJtmj6v #APS @APS_ACTION @APSsupportUK https://t.co/toUARg2zh5
-
-
Mashup Score: 0New Poster Track at JADPRO Live Announced APSHO Patient/Advocacy Perspective - The ASCO Post - 2 year(s) ago
By The ASCO Post Staff Posted: 7/26/2022 11:16:00 AM Last Updated: 7/26/2022 2:03:32 PM Abstract submission is now open for JADPRO Live 2022, taking place October 20 to 23 in Aurora, Colorado, and includes a new poster track: APSHO Patient/Advocacy Perspective Posters. This track provides patients and…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New Poster Track at JADPRO Live Announced: APSHO Patient/Advocacy Perspective https://t.co/3JoVd1pOw9 @JADPRO @APSHOorg #JADPROLive #APs
-
-
Mashup Score: 0PANLAR 2022 - Congreso Panamericano de Reumatología - 2 year(s) ago
PANLAR 2022 – Del 10 al 13 de agosto en el Hyatt Regency Hotel de Miami, Estados Unidos. El Congreso Panamerican de Reumatología ofrece las últimas novedades en artrosis, artritis psoriásica, ar
Source: PANLAR 2022Categories: Latest Headlines, RheumatologyTweet-
Register for the PANLAR 2022 Congress in Miami, Aug. 10-13. In partnership with @PanlarLeague, ACR will contribute a day-long clinical review course on Aug. 10 + a 1-hour symposium on Aug. 11, which will feature updates on #vaccines & #APS. Learn more → https://t.co/QuGrUs6agP https://t.co/3x8pjq4mAC
-
-
Mashup Score: 0Q&A: ‘Primary prevention’ the biggest challenge in managing antiphospholipid syndrome - 2 year(s) ago
Reducing the risk for thrombotic events in patients with antiphospholipid syndrome means striking the proper balance of monitoring and anticoagulation therapy, according to Richard A. Furie, MD, of Northwell Health in New York.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
"It is a big leap to put someone who has no problems at all, just these antibodies, on full-blown anticoagulation," Richard Furie, MD, told Healio #APS #RheumTwitter https://t.co/PYUBcx7FVY
-
-
Mashup Score: 0Q&A: ‘Primary prevention’ the biggest challenge in managing antiphospholipid syndrome - 2 year(s) ago
Reducing the risk for thrombotic events in patients with antiphospholipid syndrome means striking the proper balance of monitoring and anticoagulation therapy, according to Richard A. Furie, MD, of Northwell Health in New York.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Reducing the risk for thrombotic events in patients with antiphospholipid syndrome means striking the proper balance of monitoring and anticoagulation therapy #APS #RheumTwitter https://t.co/XPrtdKlVbY
-
Reducing the risk for thrombotic events in patients with antiphospholipid syndrome means striking the proper balance of monitoring and anticoagulation therapy #APS #RheumTwitter https://t.co/PYUBcx7FVY
-
-
Mashup Score: 4EULAR | Recommendations for management - 2 year(s) ago
This page lists the EULAR Recommendations for management dating back to the year 2011. Scroll to the bottom of the page to start the year 2011, scrolling upwards through the years to the present day. Each authors lists the following: The authors, the title, the publication citation, publication date and link to the final, published recommendation text. George C Drosos, Daisy Vedder, Eline…
Source: www.eular.orgCategories: Latest Headlines, RheumatologyTweet-
📣 Read the latest #EULARrecommendations 📣 🔔 #Cardiovascular risk management in RMDs, including systemic lupus erythematosus and antiphospholipid syndrome 🔔 🔗 View the publication 👉 https://t.co/4Bafok6hQu #Rheuma #SLE #APS @EMEUNET @eularYoungPARE @eularHPR https://t.co/NrJSE0hVZD
-
-
Mashup Score: 1Rapid weight loss in a patient with anti-synthetase syndrome treated with sodium–glucose cotransporter 2 inhibitors and corticosteroids - 2 year(s) ago
Dear Editor, Sodium–glucose cotransporter 2 (SGLT2) inhibitors, which block glucose reabsorption in the proximal tubules, have been used to treat type 2 diabete
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
Nawata et al. report rapid weight loss in an #APS patient treated with SGLT2 inhibitors and corticosteroids. The figure shows clinical course and fluctuations of body weight and blood urea nitrogen 👇 https://t.co/jbAxIN91UF https://t.co/1YR26HG9Wv
-
-
Mashup Score: 5Defibrotide inhibits antiphospholipid antibody‐mediated NET formation and venous thrombosis - 2 year(s) ago
Objectives Defibrotide is a heterogenous mixture of polyanionic oligonucleotides currently approved for treatment of transplant-associated veno-occlusive disease. While defibrotide has a known role …
Source: Wiley Online LibraryCategories: Latest Headlines, RheumatologyTweet-
#ResearchHighlight | Defibrotide inhibits NET-mediated thrombosis in APS models #rheumatology #APS #thrombosis Read the original research from @jasonsknight @DorukErkanMD @ACR_Journals here https://t.co/xDotDZPGJG Read our news story here https://t.co/0k1ufIGBOq
-
-
Mashup Score: 25Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Latest Headlines, RheumatologyTweet-
Recently saw a patient with #APS🩸and thrombocytopenia. Not rare, but there is lack of awareness about this association. 🕵️♂️ I always send to the fellows this great review by @jasonsknight Cryptic conspirators: thrombocytopenia and APS https://t.co/JPUDfiSQTT https://t.co/xCtarnmktT
-
❗ Risk factors for vascular & obstetric recurrence in #APS 68 triple-positive 🆚 122 non-triple pts in a French cohort 🇫🇷 📈 triple positivity was associated with a higher risk of relapse (HR 1.63; 95% CI 1.04 to 2.55). 👉 Link: https://t.co/SK0RuJ7blb @mekinian2 https://t.co/Hko7UQUhZ4